- ICH GCP
- US-Register für klinische Studien
- Klinische Studie NCT01155271
OBese Patients With Obstructive Sleep Apnea Syndrome(OSAS) and EXercise Training (OBEX1)
Comparison of 3 Exercise Training Modalities in Obese Patient With Sleep Apnea Syndrome Treated by Continue Positive Airway Pressure : a Randomized Controlled Study
The study was designed to test the following hypotheses:
In obese patients with OSAS, the benefit of the combination of exercise training + continuous positive airway pressure (CPAP) will be higher than CPAP alone in term of functional capacity, metabolic, inflammatory, cardiovascular and sleep parameters and quality of life.
In obese patients with OSAS, the benefit of training using ventilatory assistance (NIV) during cycloergometer [cycloergometer with NIV] or respiratory muscles training (spirotiger) in addition to cycloergometer [cycloergometer + spirotiger] will be higher than cycloergometer training alone [cycloergometer] in term of functional and exercise capacities.
Dyspnea during walking test and respiratory muscle strength at baseline could influence the response to combined exercise training such as [cycloergometer + NIV] or [cycloergometer + spirotiger]
Studienübersicht
Status
Bedingungen
Intervention / Behandlung
Detaillierte Beschreibung
Background: Obesity and sleep apnea syndrome lead to metabolic troubles and increasing cardiovascular risk. Furthermore, both diseases are associated with reduced exercise tolerance. We hypothesized that exercise training could be complementary to nocturnal ventilatory treatment in restoring metabolic disturbances, exercise tolerance and sleep parameters in obese patients with SAS.
Objective: To evaluate the effect of training on exercise tolerance (walking distance and dyspnea during walk)(main objective), systemic inflammation, vascular endothelial function, insulin resistance, quality of sleep and quality of life in obese patients treated by CPAP for OSAS (secondary objectives)
Methods: We proposed to conduct a controlled, randomized clinical trial comparing the efficacy of 3 different modalities of training in obese patients with SAS. After a 6-week control pre-inclusion period, patients are included in either [cycloergometer] vs. [cycloergometer with ventilatory assistance] vs. [cycloergometer + respiratory muscle exercises]. Before and after the control period, and both immediately and 9 month after training, patients perform walking test, maximal incremental test on cycloergometer, blood sampling and cardiovascular function, body composition, muscle function, quality of sleep and quality of life assessments as well as spontaneous physical activity measurement. During the 5 years following inclusion in the training program, the number of cardiovascular event is recorded every year.
An interim analysis will be carried out when 30 will have completed the third evaluation session (after the training program). The Peto's method will be used to correct the p-values.
Studientyp
Einschreibung (Tatsächlich)
Phase
- Unzutreffend
Kontakte und Standorte
Studienorte
-
-
-
Grenoble, Frankreich, 38043
- Hopital Universitaire de Grenoble
-
-
-
-
-
Quebec, Kanada, GIV 4G5
- Institut Universitaire de Cardiologie et de Pneumologie de Québec (IUCPQ)
-
-
Teilnahmekriterien
Zulassungskriterien
Studienberechtigtes Alter
Akzeptiert gesunde Freiwillige
Studienberechtigte Geschlechter
Beschreibung
Inclusion Criteria:
- OSAS (AHI > 30 before CPAP treatment)
- > 4h/d CPAP treatment adherence
- Obese patients with 35 < BMI < 45 kg/m2
- Patients who give written consent
- Patients who subscribed social insurance
Exclusion Criteria:
- Cardiovascular or respiratory failure discovered at the moment of the inclusion in the study
- Contraindication to exercise
- Pregnant or breast-feed woman
- Patients under guardianship
- Imprisoned patients
Studienplan
Wie ist die Studie aufgebaut?
Designdetails
- Hauptzweck: Behandlung
- Zuteilung: Zufällig
- Interventionsmodell: Parallele Zuordnung
- Maskierung: Single
Waffen und Interventionen
Teilnehmergruppe / Arm |
Intervention / Behandlung |
---|---|
Aktiver Komparator: ERGO
General endurance training on cycloergometer
|
12 weeks : 3 sessions per week (2 supervised sessions and 1 session at home) 1 technical visit and 1 nursing visit every two months at home for the CPAP |
Aktiver Komparator: ERGONIV/ ERGOSPIRO
General endurance training on cycloergometer using ventilatory assistance (ERGONIV) or additional respiratory muscle training (ERGOSPIRO)
|
12 weeks : 3 sessions per week (2 supervised sessions and 1 session at home) 1 technical visit and 1 nursing visit every two months at home for the CPAP |
Was misst die Studie?
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
---|---|---|
Change in exercise tolerance during walking test
Zeitfenster: After control period (6th wk) vs. after training period (18th wk)
|
|
After control period (6th wk) vs. after training period (18th wk)
|
Sekundäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
---|---|---|
Changes in Aerobic capacity
Zeitfenster: After control period (6th wk) vs. after training period (18th and 52th wks)
|
Maximal oxygen consumption
|
After control period (6th wk) vs. after training period (18th and 52th wks)
|
Changes in cardiovascular and metabolic function
Zeitfenster: After control period (6th wk) vs. after training period (18th and 52th wks)
|
Pulse wave velocity, peripheral arterial tone, BP, inflammatory and metabolic plasmatic markers
|
After control period (6th wk) vs. after training period (18th and 52th wks)
|
Changes in sleep parameters and Quality Of life
Zeitfenster: After control period (6th wk) vs. after training period (18th and 52th wks)
|
Nocturnal oxygen saturation, CPAP data, Epworth questionnaire, Short Form (36) Health Survey questionnaire
|
After control period (6th wk) vs. after training period (18th and 52th wks)
|
Number of cardiovascular events per year
Zeitfenster: Every year from the 1st to the 5th year
|
Questionnaire sent to the patient by mail
|
Every year from the 1st to the 5th year
|
Changes in body composition
Zeitfenster: After control period (6th wk) vs. after training period (18th and 52th wks)
|
Fat mass and fat-mass index Fat-free mass and fat-free mass index assessed by impedancemetry measurements
|
After control period (6th wk) vs. after training period (18th and 52th wks)
|
Change in physical activity and sleep duration
Zeitfenster: After control period (6th wk) vs. after training period (18th and 52th wks)
|
Number of hour per day of physical activity at 1, 2, 3 or 4 Metabolic Equivalents (METS); Number of steps per day; Sleep to lying position duration ratio
|
After control period (6th wk) vs. after training period (18th and 52th wks)
|
Change in exercise tolerance during walking test
Zeitfenster: After control period (6th wk) vs. after trainng (52th wk)
|
|
After control period (6th wk) vs. after trainng (52th wk)
|
Change in physiological variables during the control period
Zeitfenster: Before (1st) vs. after control period (6th wk)
|
|
Before (1st) vs. after control period (6th wk)
|
Baseline characteristics
Zeitfenster: Before control period (1st week) or after the control period (6th week)
|
|
Before control period (1st week) or after the control period (6th week)
|
Mitarbeiter und Ermittler
Sponsor
Mitarbeiter
Ermittler
- Hauptermittler: Jean-Louis Pépin, MD, PhD, Laboratoire EFCR, CHU de Grenoble, 38043, Grenoble, France
Publikationen und hilfreiche Links
Studienaufzeichnungsdaten
Haupttermine studieren
Studienbeginn
Primärer Abschluss (Tatsächlich)
Studienabschluss (Voraussichtlich)
Studienanmeldedaten
Zuerst eingereicht
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst gepostet (Schätzen)
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Tatsächlich)
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Zuletzt verifiziert
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Zusätzliche relevante MeSH-Bedingungen
Andere Studien-ID-Nummern
- AGIR-03
Arzneimittel- und Geräteinformationen, Studienunterlagen
Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt
Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt
Produkt, das in den USA hergestellt und aus den USA exportiert wird
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .
Klinische Studien zur Rehabilitation
-
Tuba MadenAbgeschlossenMultiple Sklerose | Posturales Gleichgewicht | Erkrankungen der zervikalen Region Nr | Muskeltonus | PropriozeptionTruthahn
-
I.R.C.C.S. Fondazione Santa LuciaAbgeschlossenMultiple SkleroseItalien
-
Centre Hospitalier Universitaire de Saint EtienneMinistry of Health, FranceRekrutierungPulmonale HypertonieFrankreich
-
Campus Bio-Medico UniversityRekrutierungSchmerzen im unteren Rücken | Rehabilitation | Orthopädische Störung | Physiotherapie | KernstärkungItalien
-
Istituti Clinici Scientifici Maugeri SpANoch keine RekrutierungKognitive Beeinträchtigung | Demenz | Vaskuläre Demenz | Demenz, gemischt | Komorbiditäten und Begleiterkrankungen
-
Hopital FochRekrutierungVerletzungen des RückenmarksFrankreich
-
IRCCS San Camillo, Venezia, ItalyIRCCS San Raffaele; Istituto Universitario di Studi Superiori PaviaRekrutierungStreicheln | Schizophrenie | Schädel-Hirn-TraumaItalien
-
Centro Hospitalar de Vila Nova de Gaia/Espinho,...Noch keine RekrutierungArthritis, Rheuma | Arthritis, Psoriasis | Einschränkung, Mobilität | Handdeformität | Handarthrose | Deformität, HandPortugal
-
Afyonkarahisar Health Sciences UniversityAbgeschlossenZerebralparese | Rehabilitation | Handfunktionen | Robotische RehabilitationTruthahn
-
Hacettepe UniversityAbgeschlossenBankart-LäsionTruthahn